Related Experiment Videos
Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial
1Abteilung für Neonatologie, Universitäts-Frauenklinik, Zürich, Switzerland.
European Journal of Pediatrics
|April 1, 1988
Summary
Caffeine citrate did not reduce hypoxaemic episodes or bradycardia in preterm infants. This study suggests prophylactic caffeine offers minimal benefit for these risks in vulnerable newborns.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Pediatrics
Background:
- Preterm infants, particularly those born at 32 weeks' gestation or less, are at high risk for hypoxaemic episodes and bradycardia.
- Recurrent hypoxaemic events can lead to significant short-term and long-term morbidities in neonates.
- Caffeine citrate is often used in neonatal care, but its prophylactic efficacy for preventing these specific events requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of prophylactic caffeine citrate in reducing recurrent hypoxaemic episodes in preterm infants.
- To assess the impact of caffeine citrate on the incidence of bradycardia in this vulnerable population.
- To test the hypothesis that caffeine reduces hypoxaemic episodes from 50% to 25%.
Main Methods:
- A randomized controlled trial involving 50 spontaneously breathing preterm infants (≤32 weeks' gestation).
- Infants received either caffeine citrate (loading dose 20 mg/kg, maintenance 10 mg/kg/day) or a placebo (NaCl 0.9%) for 50 hours.
- Continuous monitoring of transcutaneous oxygen tension (tcPO2) and heart rate using computer analysis.
Main Results:
- The mean proportion of infants with >6 hypoxaemic episodes per 12h was higher in the caffeine group (57%) than the placebo group (51%).
- No statistically significant difference was observed in the proportion of infants experiencing >6 bradycardia episodes per 12h between the caffeine (79%) and placebo (86%) groups.
- Serum caffeine concentrations confirmed adequate drug levels in the treatment group.
Conclusions:
- Prophylactic caffeine citrate demonstrated minimal to no effect on reducing hypoxaemic episodes or bradycardia in small preterm infants.
- The study confidently rejects the clinically significant 50% reduction in hypoxaemic episodes initially hypothesized.
- Findings suggest current prophylactic caffeine protocols may not be effective for preventing these specific adverse events in this population.